Abrogation of MMP-9 Gene Protects Against the Development of Retinopathy in Diabetic Mice by Preventing Mitochondrial Damage

被引:135
作者
Kowluru, Renu A. [1 ]
Mohammad, Ghulam [1 ]
dos Santos, Julia M. [1 ]
Zhong, Qing [1 ]
机构
[1] Wayne State Univ, Kresge Eye Inst, Detroit, MI 48202 USA
基金
美国国家卫生研究院;
关键词
CAPILLARY CELL-DEATH; BLOOD-RETINAL BARRIER; MATRIX METALLOPROTEINASES; DYSFUNCTION; MATRIX-METALLOPROTEINASE-9; APOPTOSIS; GALACTOSEMIA; MECHANISMS; MEMBRANE; PROTEINS;
D O I
10.2337/db11-0816
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-In the development of diabetic retinopathy, mitochondrial dysfunction is considered to play an important role in the apoptosis of retinal capillary cells. Diabetes activates matrix metalloproteinase-9 (MMP-9) in the retina and its capillary cells, and activated MMP-9 becomes proapoptotic. The objective of this study is to elucidate the plausible mechanism by which active MMP-9 contributes to the mitochondrial dysfunction in the retina. RESEARCH DESIGN AND METHODS-Using MMP-9 gene knockout (MMP-KO) mice, we investigated the effect of MMP-9 regulation on diabetes-induced increased retinal capillary cell apoptosis, development of retinopathy, mitochondrial dysfunction and ultrastructure, and mitochondrial DNA (mtDNA) damage. To understand how diabetes increases mitochondrial accumulation of MMP-9, interactions between MMP-9 and chaperone proteins (heat shock protein [Hsp)] 70 and Hsp60) were evaluated. The results were confirmed in the retinal mitochondria from human donors with diabetic retinopathy, and in isolated retinal endothelial cells transfected with MMP-9 small interfering RNA (siRNA). RESULTS-Retinal microvasculature of MMP-KO mice, diabetic for 7 months, did not show increased apoptosis and pathology characteristic of retinopathy. In the same MMP-KO diabetic mice, activation of MMP-9 and dysfunction of the mitochondria were prevented, and electron microscopy of the retinal microvasculature region revealed normal mitochondrial matrix and packed lamellar cristae. Damage to mtDNA was protected, and the binding of MMP-9 with Hsp70 or Hsp60 was also normal. As in the retina from wild-type diabetic mice, activation of mitochondrial MMP-9 and alterations in the binding of MMP-9 with chaperone proteins were also observed in the retina from donors with diabetic retinopathy. In endothelial cells transfected with MMP-9 siRNA, high glucose-induced damage to the mitochondria and the chaperone machinery was ameliorated. CONCLUSIONS-Regulation of activated MMP-9 prevents retinal capillary cells from undergoing apoptosis by protecting mitochondrial ultrastructure and function and preventing mtDNA damage. Thus, MMP-9 inhibitors could have potential therapeutic value in preventing the development of diabetic retinopathy by preventing the continuation of the vicious cycle of mitochondrial damage. Diabetes 60:3023-3033, 2011
引用
收藏
页码:3023 / 3033
页数:11
相关论文
共 39 条
[21]   Matrix metalloproteinases (MMPs) in health and disease: an overview [J].
Malemud, CJ .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 :1696-1701
[22]   Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy [J].
Mizutani, M ;
Kern, TS ;
Lorenzi, M .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2883-2890
[23]   Muller cell changes in human diabetic retinopathy [J].
Mizutani, M ;
Gerhardinger, C ;
Lorenzi, M .
DIABETES, 1998, 47 (03) :445-449
[24]  
Mohammad G, 2011, J CELL PHYSL 0512
[25]   Novel Role of Mitochondrial Matrix Metalloproteinase-2 in the Development of Diabetic Retinopathy [J].
Mohammad, Ghulam ;
Kowluru, Renu A. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (06) :3832-3841
[26]   Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction [J].
Mohammad, Ghulam ;
Kowluru, Renu A. .
LABORATORY INVESTIGATION, 2010, 90 (09) :1365-1372
[27]   Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia [J].
Moshal, Karni S. ;
Tipparaju, Srinivas M. ;
Vacek, Thomas P. ;
Kumar, Munish ;
Singh, Mahavir ;
Frank, Iluiana E. ;
Patibandla, Phani K. ;
Tyagi, Neetu ;
Rai, Jayesh ;
Metreveli, Naira ;
Rodriguez, Walter E. ;
Tseng, Michael T. ;
Tyagi, Suresh C. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 295 (02) :H890-H897
[28]  
Muroski ME, 2008, CURR PHARM BIOTECHNO, V9, P34
[29]   Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes [J].
Navaratna, Deepti ;
McGuire, Paul G. ;
Menicucci, Gina ;
Das, Arup .
DIABETES, 2007, 56 (09) :2380-2387
[30]   Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice [J].
Ovechkin, AV ;
Tyagi, N ;
Rodriguez, WE ;
Hayden, MR ;
Moshal, KS ;
Tyagi, SC .
JOURNAL OF APPLIED PHYSIOLOGY, 2005, 99 (06) :2398-2405